Antiglucocorticoid treatment of depression: double-blind ketoconazole (Q41675968)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on April 1999

Language	Label	Description	Also known as
English	Antiglucocorticoid treatment of depression: double-blind ketoconazole	scientific article published on April 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Antiglucocorticoid treatment of depression: double-blind ketoconazole (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Owen M. Wolkowitz

1

object named as

Wolkowitz OM

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

author name string

Reus VI

2

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Chan T

3

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Manfredi F

4

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Raum W

5

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Johnson R

6

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Canick J

7

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

1070-1074

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

Potentiation of fluoxetine by aminoglutethimide, an adrenal steroid suppressant, in obsessive-compulsive disorder resistant to SSRIs: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

Steroids and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

Neuroendocrine responses to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

Treatment of major depression with metyrapone and hydrocortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

Antiglucocorticoid treatments in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

The DST as a predictor of outcome in depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

The use of ketoconazole as an inhibitor of steroid production

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

Nitroimidazole derivatives inhibit anterior pituitary cell function apparently by a direct effect on the catalytic subunit of the adenylate cyclase holoenzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

Ketoconazole administration in hypercortisolemic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

Dehydroepiandrosterone (DHEA) treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900267-4

7 January 2021

Identifiers

10.1016/S0006-3223(98)00267-4

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41675968&oldid=1925851860"